The effect of Montelukast administration on rhabdomyolysis state

Phase 3

Recruiting

• Conditions: Rhabdomyolysis.; Rhabdomyolysis; M62.82

• Registration Number: IRCT20210720051946N2
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 May 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients that admit with drug or substance toxicity and progress to rhabdomyolysis

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cpk. Timepoint: Daily. Method of measurement: Labratory.